<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DLBCL tumor microenvironment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/dlbcl-tumor-microenvironment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 26 Dec 2025 15:24:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>DLBCL tumor microenvironment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>FASN Drives Immunosuppression in DLBCL Tumors</title>
		<link>https://bioengineer.org/fasn-drives-immunosuppression-in-dlbcl-tumors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 26 Dec 2025 15:23:57 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer immunotherapy targets]]></category>
		<category><![CDATA[DLBCL tumor microenvironment]]></category>
		<category><![CDATA[FASN in DLBCL]]></category>
		<category><![CDATA[fatty acid metabolism in cancer]]></category>
		<category><![CDATA[immunosuppressive tumor microenvironment]]></category>
		<category><![CDATA[Lipid metabolism immune evasion]]></category>
		<category><![CDATA[Makalenin içeriğine ve odak noktalarına göre en uygun 5 etiket: **FASN immunosuppression]]></category>
		<category><![CDATA[metabolic immune regulation in lymphoma]]></category>
		<category><![CDATA[Metabolic immunotherapy** **Açıklama:** 1. **FASN immunosuppression:** Makalenin ana bulgusu ve başlığındaki temel konu. FASN'in immünsupresif etk]]></category>
		<category><![CDATA[Metabolic Reprogramming]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fasn-drives-immunosuppression-in-dlbcl-tumors/</guid>

					<description><![CDATA[The intricate relationship between cellular metabolism and immune regulation has long been a focal point in cancer research, especially within the realm of hematologic malignancies. In a groundbreaking study published in Medical Oncology, researchers Cheng, Wang, Zhang, and colleagues illuminate the critical role of fatty acid synthase (FASN) in creating an immunosuppressive microenvironment in diffuse [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">311484</post-id>	</item>
	</channel>
</rss>
